Read the original: AIM ImmunoTech Announces Publication of Positive Findings from a Pre-Clinical Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the...
Read the original: AIM ImmunoTech Announces Publication of Positive Findings from a Pre-Clinical Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the...
Read the rest here: IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2023
Excerpt from: Monthly information related to total number of voting rights and shares composing the share capital - June 26, 2023
Excerpt from: IMUNON Unveils New Manufacturing Capabilities at Huntsville’s HudsonAlpha Biotech Campus
Originally posted here: Paratek Pharmaceuticals Acknowledges Receipt of NexPoint Letter
Go here to read the rest: CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA
View post: FDA Issues Complete Response Letter (CRL) for Aflibercept 8 mg Biologics License Application Solely Due to an Ongoing Review of Inspection Findings at...
Link: Two-year Results for Aflibercept 8 mg from Pivotal PHOTON Trial Demonstrate Durable Vision Gains at Extended Dosing Intervals in Diabetic Macular...
Original post: Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
Read this article: SIGA CEO Phil Gomez, PhD, to Present on Smallpox and Orthopox Preparedness at NATO Chemical, Biological, Radiological & Nuclear Medical Symposium
Recent Comments